Psychiatric factors in asthma: implications for diagnosis and therapy.

Simon Rietveld, Thomas L Creer
{"title":"Psychiatric factors in asthma: implications for diagnosis and therapy.","authors":"Simon Rietveld,&nbsp;Thomas L Creer","doi":"10.1007/BF03256634","DOIUrl":null,"url":null,"abstract":"<p><p>Emotional factors are an obstacle in the diagnosis and management of asthma. This review discusses three problem patterns: negative emotions in relatively normal patients with asthma; patients presenting possible functional symptoms and; patients presenting asthma in conjunction with psychiatric deviations. Negative emotions influence the symptoms and management of asthma, even in relatively normal patients. Psychogenic symptoms appear normal, but culminate in functional symptoms in a minority of patients. Diagnosing and treating asthma in patients with comorbid asthma and psychiatric symptoms is very difficult. On the one hand, treating asthma may often be just treating the emotions. On the other hand, negative emotions make the treatment of asthma guesswork. Physicians should estimate emotional influences in their patients' symptoms for an optimal evaluation of medication efficacy. Assessment and analysis of emotional factors surrounding exacerbations seems essential, e.g. emotional precipitants of asthma and asthma-evoked negative emotions. Moreover, patients should be informed about stress-induced breathlessness and the consequences of overuse of bronchodilators. When patients present with atypical symptoms, or do not properly respond to asthma medication, functional symptoms should be suspected. Psychiatric analysis may often lead to the conclusion that symptoms have a functional basis. In patients with comorbid asthma and anxiety disorders, asthma should be the focus for treatment since difficult-to-control asthma often causes anxiety problems in the first place. Moreover, panic-like symptoms in asthma are often related to sudden onset asthma exacerbations. However, in patients with comorbid asthma and depression, depression should become the focus of treatment. The reason is that optimal treatment of depressive asthmatics is probably impossible. Special issues include specific problems with children, compliance problems, and physicians' dilemmas regarding the simultaneous treatment of asthma and psychiatric symptoms.</p>","PeriodicalId":86933,"journal":{"name":"American journal of respiratory medicine : drugs, devices, and other interventions","volume":"2 1","pages":"1-10"},"PeriodicalIF":0.0000,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF03256634","citationCount":"30","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of respiratory medicine : drugs, devices, and other interventions","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/BF03256634","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 30

Abstract

Emotional factors are an obstacle in the diagnosis and management of asthma. This review discusses three problem patterns: negative emotions in relatively normal patients with asthma; patients presenting possible functional symptoms and; patients presenting asthma in conjunction with psychiatric deviations. Negative emotions influence the symptoms and management of asthma, even in relatively normal patients. Psychogenic symptoms appear normal, but culminate in functional symptoms in a minority of patients. Diagnosing and treating asthma in patients with comorbid asthma and psychiatric symptoms is very difficult. On the one hand, treating asthma may often be just treating the emotions. On the other hand, negative emotions make the treatment of asthma guesswork. Physicians should estimate emotional influences in their patients' symptoms for an optimal evaluation of medication efficacy. Assessment and analysis of emotional factors surrounding exacerbations seems essential, e.g. emotional precipitants of asthma and asthma-evoked negative emotions. Moreover, patients should be informed about stress-induced breathlessness and the consequences of overuse of bronchodilators. When patients present with atypical symptoms, or do not properly respond to asthma medication, functional symptoms should be suspected. Psychiatric analysis may often lead to the conclusion that symptoms have a functional basis. In patients with comorbid asthma and anxiety disorders, asthma should be the focus for treatment since difficult-to-control asthma often causes anxiety problems in the first place. Moreover, panic-like symptoms in asthma are often related to sudden onset asthma exacerbations. However, in patients with comorbid asthma and depression, depression should become the focus of treatment. The reason is that optimal treatment of depressive asthmatics is probably impossible. Special issues include specific problems with children, compliance problems, and physicians' dilemmas regarding the simultaneous treatment of asthma and psychiatric symptoms.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
哮喘的精神因素:诊断和治疗的意义。
情绪因素是哮喘诊断和治疗的障碍。本文讨论了三种问题模式:相对正常哮喘患者的负性情绪;可能出现功能性症状的患者;伴有精神疾病的哮喘患者。即使在相对正常的患者中,负面情绪也会影响哮喘的症状和管理。心因性症状表现正常,但少数患者最终表现为功能性症状。诊断和治疗合并哮喘和精神症状的哮喘患者是非常困难的。一方面,治疗哮喘通常只是治疗情绪。另一方面,消极情绪会使哮喘的治疗成为猜测。医生应该估计情绪对患者症状的影响,以便对药物疗效进行最佳评估。评估和分析围绕病情恶化的情绪因素似乎是必要的,例如哮喘和哮喘引起的负面情绪的情绪诱因。此外,应告知患者压力引起的呼吸困难和过度使用支气管扩张剂的后果。当患者出现非典型症状,或对哮喘药物没有适当反应时,应怀疑是功能性症状。精神病学分析常常得出这样的结论:症状具有功能基础。对于合并哮喘和焦虑症的患者,哮喘应该是治疗的重点,因为难以控制的哮喘往往首先引起焦虑问题。此外,哮喘的惊恐样症状通常与突然发作的哮喘加重有关。然而,对于合并哮喘和抑郁症的患者,抑郁症应成为治疗的重点。原因是抑郁症哮喘患者的最佳治疗可能是不可能的。特殊问题包括儿童的特殊问题、依从性问题以及医生在同时治疗哮喘和精神症状方面的困境。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The emerging role of leukotriene modifiers in allergic rhinitis. Is there a role for systemic corticosteroids in the management of stable chronic obstructive pulmonary disease? Pseudomonal infections in patients with COPD: epidemiology and management. Treatment of community-acquired lower respiratory tract infections during pregnancy. Anti-interleukin-5 monoclonal antibodies: preclinical and clinical evidence in asthma models.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1